Upload
jagannath-singh
View
215
Download
0
Embed Size (px)
Citation preview
7/30/2019 PRESENTATION ON DENGUE.pptx
1/29
A CROSS SECTIONAL STUDY TO KNOW THE
RELATIONSHIP BETWEEN SEVERITY OF
THROMBOCYTOPENIA AND SEVERITY OFDENGUE IN PEDIATRIC WARD OF GGH,
KURNOOL
By:K. JagannathSingh.
Teacher
Indus High SchoolKurnool
7/30/2019 PRESENTATION ON DENGUE.pptx
2/29
Dengue fever is a major public health problem intropical and subtropical countries
The reasons for the emergence of this disease arecomplex
Effective mosquito control is virtuallynonexistent in most dengue-endemic countries
Major global demographic changes have occurred
Uncontrolled urbanizationConcurrent population growth
Substandard housing, inadequate water,
sewer, and waste management systems
7/30/2019 PRESENTATION ON DENGUE.pptx
3/29
To reveal the prevalence of Dengue amongsuspected case of dengue(VHF)
Understand the relationship betweenseverity of thrombocytopenia versusseverity of Dengue
To study whether the platelet count bearsany relation with new WHO classificationof Dengue(2009)
7/30/2019 PRESENTATION ON DENGUE.pptx
4/29
7/30/2019 PRESENTATION ON DENGUE.pptx
5/29
Dengue is cause by a RNA virusThis virus is a member of the viral familyFlaviviridae.
Dengue virus
7/30/2019 PRESENTATION ON DENGUE.pptx
6/29
Aedes aegypti Aedes albopictus
7/30/2019 PRESENTATION ON DENGUE.pptx
7/29
2-7 days
>4 days
2days
7/30/2019 PRESENTATION ON DENGUE.pptx
8/29
7/30/2019 PRESENTATION ON DENGUE.pptx
9/29
7/30/2019 PRESENTATION ON DENGUE.pptx
10/29
Dengue is one disease entity withdifferent clinical presentationsandoften withunpredictableclinicalevolutionandoutcome
7/30/2019 PRESENTATION ON DENGUE.pptx
11/29
7/30/2019 PRESENTATION ON DENGUE.pptx
12/29
7/30/2019 PRESENTATION ON DENGUE.pptx
13/29
7/30/2019 PRESENTATION ON DENGUE.pptx
14/29
Study settings: Pediatric ward of KMC/GGH Kurnool
Study design :Cross-sectional study
Study subjects:70 Sampling method: All suspected cases of
Dengue admitted in pediatric ward
Study period: Schedule 1.06.2011to19.09.2011
Data collected was analyzed in MS
excel
7/30/2019 PRESENTATION ON DENGUE.pptx
15/29
Mean age: 4 years Mode for age:3 Median for age:7 years
Range:7 months to 14 years
Mean platelet count:33,214 Mode:40,000 Median:47,000 Range:2000 to 1,00,000
7/30/2019 PRESENTATION ON DENGUE.pptx
16/29
7/30/2019 PRESENTATION ON DENGUE.pptx
17/29
7/30/2019 PRESENTATION ON DENGUE.pptx
18/29
7/30/2019 PRESENTATION ON DENGUE.pptx
19/29
7/30/2019 PRESENTATION ON DENGUE.pptx
20/29
7/30/2019 PRESENTATION ON DENGUE.pptx
21/29
7/30/2019 PRESENTATION ON DENGUE.pptx
22/29
7/30/2019 PRESENTATION ON DENGUE.pptx
23/29
Platelets Severe Dengue (+ve) Severe Dengue (-ve)Total
20,000 10 6 16
> 20,000 14 40 54
Total 24 46 70
Chi square value > 7.29P value < 0.01 (highly significant)df=1
7/30/2019 PRESENTATION ON DENGUE.pptx
24/29
In my study 43 were +Ve for dengueamong them 24 were diagnosed as severDengue out of 70 cases of Dengue
In K. Oishi and all in,Nagasakiuniversity,Japan. 38 were +Ve for severdengue among 78 cases of secondary
dengue
7/30/2019 PRESENTATION ON DENGUE.pptx
25/29
The prevalence rate of Dengue is (43/70 100) Age wise distribution of Dengue cases Gender distribution of dengue Distribution of cases according to WHO
classification of Dengue Relation among platelet counts and different forms
of Dengue Case fatality rate (3/70 100)
The strength of association between severity ofDengue and severity of thrombocytopenia wasfound to be statistically significant with a P value
7/30/2019 PRESENTATION ON DENGUE.pptx
26/29
Special thanks to my beloved Professors:Dr. P.Sudhakar Rao MD Gen Med
Dr. A.Sreedevi Prof & HOD of SPM
Assistant professor:Dr.S.Cynthia SubhapradaMy colleagues:
Bala Kumar.D
Divya.B
Bhupathi Naidu.K
7/30/2019 PRESENTATION ON DENGUE.pptx
27/29
WHO Library Cataloguing-in-Publication Data
Dengue: guidelines for diagnosis, treatment, prevention and control -- New
edition.
1.Dengue - diagnosis. 2.Dengue - therapy. 3.Dengue - prevention and control.
4.Endemic Diseases -
prevention and control. 5.Fluid therapy. 6.Diagnosis, differential. 7.Disease
outbreaks - prevention and
control. 8.Mosquito control. 9.Guidelines. I.World Health Organization.
ISBN 978 92 4 1 Mayo clinic, (2010). Dengue fever symptoms. Retrieved April 19, 2010 from
http://www.mayoclinic.com/health/dengue_fever/DS01028/DSECTION=symptoms
54787 1 (NLM classification: WC 528) World Health Organization, (2009). Dengue and Dengue haemorrhagic fever.
Retrieved April 19, 2010 from
http://www.who.int/mediacentre/factsheets/fs117/en
http://www.mayoclinic.com/health/dengue_fever/DS01028/DSECTION=symptomshttp://www.who.int/mediacentre/factsheets/fs117/en/http://www.who.int/mediacentre/factsheets/fs117/en/http://www.mayoclinic.com/health/dengue_fever/DS01028/DSECTION=symptoms7/30/2019 PRESENTATION ON DENGUE.pptx
28/29
:
Dengue Fever , disease information:http://www.cdc.gov/ncidod/Diseases/submen
us/sub_dengue.htm
CDC-Dengue:http://www.cdc.gov/ncidod/dvbid/dengue/
WHO/Dengue/dengue haemorrhagic fever:http://www.who.int/csr/disease/dengue/en/
http://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htmhttp://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htmhttp://www.cdc.gov/ncidod/dvbid/dengue/http://www.cdc.gov/ncidod/dvbid/dengue/http://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htmhttp://www.cdc.gov/ncidod/Diseases/sudmenus/sub_dengue.htm7/30/2019 PRESENTATION ON DENGUE.pptx
29/29
Thank you